Brain and Heart Interconnectome

Brain and Heart Interconnectome is a biotechnology company focused on the emerging field of the brain-heart axis. The company develops therapeutic solutions by targeting the complex bidirectional communication pathways between the central nervous system and the cardiovascular system. Their research aims to address co-morbidities where neurological decline and cardiac dysfunction intersect, such as in heart failure-induced cognitive impairment. By leveraging a proprietary discovery platform, the company identifies novel biomarkers and therapeutic targets within the interconnectome to treat systemic diseases. Their approach represents a shift toward holistic, multi-organ drug development in the life sciences sector.